Listed companies
Professional, scientific and technical: South Korean listed companies
138 companies, largest first.
Companies
| Company | Staff | Women | Pay gap |
|---|---|---|---|
| Samsung E&A 028050 | 5,249 | 10.9% | 23.4% |
| Korea Electronic Power Industrial Development 130660 | 3,614 | 4.2% | 30.1% |
| Dohwa Engineering 002150 | 2,912 | 11.9% | 33.6% |
| KEPCO Engineering & Construction Company 052690 | 2,466 | 21.2% | 28.6% |
| POSCO DX Company 022100 | 2,103 | 19.1% | 18.7% |
| Yooshin Engineering 054930 | 1,988 | 10.1% | 32.3% |
| Korea Engineering Consultants 023350 | 1,907 | 9.5% | 35.5% |
| Cheil Worldwide 030000 | 1,511 | 54.3% | 20.3% |
| Heerim Architects & Planners 037440 | 1,405 | 21.3% | 18.4% |
| Hanyang Eng 045100 | 1,256 | 11.5% | 18.5% |
| Hanmi Global 053690 | 1,120 | 12.6% | 27.4% |
| Innocean Worldwide 214320 | 1,001 | 51.1% | 28.0% |
| GC Cell 144510 | 806 | 35.4% | 6.0% |
| Doosan Tesna 131970 | 786 | 36.9% | 22.8% |
| HS Ad 035000 | 763 | 51.9% | 28.6% |
| SUNGDO Engineering & Construction 037350 | 618 | 7.4% | 26.3% |
| HD Hyundai Marine Solution 443060 | 583 | 23.2% | 39.0% |
| Orbitech 046120 | 556 | 8.6% | 20.3% |
| Revu 443250 | 534 | 56.0% | 37.3% |
| HCT 072990 | 522 | 15.9% | 24.2% |
| C&R Research 359090 | 522 | 82.0% | 26.9% |
| Macrogen 038290 | 488 | 53.9% | 22.0% |
| kt nasmedia 089600 | 400 | 58.8% | 15.5% |
| DreamCIS 223250 | 395 | 79.7% | 12.3% |
| Emnet 123570 | 371 | 65.5% | 27.5% |
| Nepes Ark 330860 | 346 | 29.5% | 29.7% |
| SM Culture & Contents 048550 | 345 | 61.4% | 17.2% |
| WOOJIN Ntec 457550 | 332 | 6.9% | 34.1% |
| DT&CRO 383930 | 314 | 60.8% | 6.5% |
| Dt&C 187220 | 306 | 21.6% | 45.9% |
| Oricom 010470 | 305 | 63.3% | 42.1% |
| PlayD 237820 | 288 | 68.4% | 10.9% |
| Chai Communication 351870 | 275 | 62.5% | 29.2% |
| SK Biopharmaceuticals 326030 | 272 | 50.0% | 19.8% |
| SemiFive 490470 | 270 | 25.9% | 31.6% |
| Itek 119830 | 260 | 37.3% | 18.9% |
| Incross 216050 | 258 | 51.9% | 15.8% |
| Macromill Embrain 169330 | 256 | 70.3% | 29.9% |
| Biotoxtech 086040 | 241 | 54.4% | -1.7% |
| Quality Reliability Technology 405100 | 218 | 26.1% | 25.7% |
| 3billion 394800 | 196 | 45.9% | 8.0% |
| Aurora World 039830 | 187 | 50.8% | 12.8% |
| HLB Pharmaceutical 047920 | 185 | 49.7% | 21.4% |
| LigaChem Biosciences 141080 | 180 | 53.3% | 43.9% |
| Jeio 418550 | 170 | 15.3% | 30.6% |
| Sigong Tech 020710 | 169 | 43.8% | 24.9% |
| GC 005250 | 163 | 39.3% | 22.1% |
| Alteogen 196170 | 161 | 56.5% | 65.1% |
| Wise birds 273060 | 160 | 68.8% | 39.3% |
| Dreaminsight 362990 | 158 | 65.2% | 16.0% |
| Hansung Cleantech 066980 | 152 | 13.8% | 38.1% |
| HLB bioStep 278650 | 150 | 38.0% | 29.8% |
| Voronoi 310210 | 149 | 51.7% | 42.3% |
| Curocell 372320 | 146 | 55.5% | 5.6% |
| LabGenomics 084650 | 142 | 36.6% | 17.0% |
| BioInfra 199730 | 141 | 68.8% | 43.5% |
| JS Link 127120 | 139 | 48.2% | 25.2% |
| GC Genome 340450 | 131 | 63.4% | 26.6% |
| Kolmar BioTech 215380 | 127 | 41.7% | 7.9% |
| Carelabs 263700 | 125 | 49.6% | 46.1% |
| Mobidays 363260 | 124 | 59.7% | 30.7% |
| P&K Skin Research Center 347740 | 121 | 81.0% | 26.8% |
| Fescaro 0015S0 | 111 | 21.6% | 7.6% |
| Penetrium Bioscience 187660 | 110 | 73.6% | 33.6% |
| Gridwiz 453450 | 107 | 31.8% | 18.2% |
| CJ Bioscience 311690 | 102 | 51.0% | 19.3% |
| HEM Pharma 376270 | 101 | 60.4% | 54.7% |
| ZGOO Holdings 221800 | 98 | 41.8% | 29.2% |
| CG Invites 083790 | 92 | 50.0% | 33.3% |
| Vaxcell-Bio Therapeutics 323990 | 91 | 51.6% | 38.5% |
| Organoid Sciences 476040 | 89 | 55.1% | -9.6% |
| Psomagen 950200 | 88 | 52.3% | 23.8% |
| NBT 236810 | 87 | 32.2% | 45.5% |
| Naturalendo Tech 168330 | 83 | 51.8% | 36.3% |
| GI Innovation 358570 | 82 | 48.8% | 16.4% |
| OliX Pharmaceuticals 226950 | 76 | 52.6% | 21.9% |
| Genomictree 228760 | 76 | 56.6% | 41.5% |
| Soulbrain Holdings 036830 | 75 | 32.0% | 26.6% |
| Inventage Lab 389470 | 73 | 26.0% | 20.0% |
| Genematrix 109820 | 69 | 52.2% | 13.6% |
| TiumBio 321550 | 67 | 46.3% | 12.7% |
| Prestige BioPharma 950210 | 67 | 73.1% | 13.3% |
| Genexine 095700 | 66 | 69.7% | 12.2% |
| ToolGen 199800 | 64 | 51.6% | 44.9% |
| IMBdx 461030 | 64 | 56.3% | 38.7% |
| Eone Diagnomics Genome Center 245620 | 63 | 57.1% | 40.2% |
| SLS Bio 246250 | 63 | 60.3% | 6.5% |
| Dx & Vx 180400 | 62 | 45.2% | 38.7% |
| Geninus 389030 | 59 | 47.5% | 32.6% |
| Y-Biologics 338840 | 58 | 58.6% | 34.4% |
| KoBioLabs 348150 | 57 | 54.4% | 37.7% |
| SillaJen 215600 | 56 | 50.0% | -5.0% |
| NGeneBio 354200 | 55 | 56.4% | 40.1% |
| MOA Life Plus 142760 | 54 | 40.7% | 28.7% |
| MedPacto 235980 | 54 | 48.1% | 22.3% |
| Ecoeye 448280 | 54 | 63.0% | 39.3% |
| Aptn 270520 | 53 | 28.3% | 6.8% |
| Proteina 468530 | 53 | 47.2% | 25.0% |
| Aimed Bio 0009K0 | 52 | 55.8% | 26.0% |
| NICE Holdings 034310 | 50 | 14.0% | 57.4% |
| EyeGene 185490 | 49 | 42.9% | 34.1% |
| Aribiolab 261780 | 49 | 71.4% | 24.7% |
| Cellid 299660 | 49 | 51.0% | 19.0% |
| Daesung Holdings 016710 | 47 | 36.2% | 55.4% |
| Simmtech Holdings 036710 | 47 | 25.5% | 27.8% |
| Aptabio Therapeutics 293780 | 45 | 62.2% | 14.1% |
| Helixmith 084990 | 44 | 40.9% | 39.6% |
| Choolip & Sciences 291650 | 44 | 45.5% | 27.7% |
| Quratis 348080 | 44 | 40.9% | 25.8% |
| IntoCell 287840 | 43 | 53.5% | -2.8% |
| ViGenCell 308080 | 43 | 62.8% | -42.4% |
| IMBiologics 493280 | 41 | 58.5% | -7.4% |
| Jeil Pharma Holdings 002620 | 40 | 37.5% | 53.5% |
| BK Holdings 050090 | 40 | 47.5% | 16.0% |
| Oncocross 382150 | 40 | 30.0% | 19.4% |
| NeoImmuneTech 950220 | 40 | 50.0% | 21.1% |
| Cytogen 217330 | 39 | 46.2% | 31.3% |
| Rznomics 476830 | 39 | 56.4% | 24.0% |
| Onconic Therapeutics 476060 | 38 | 63.2% | 1.3% |
| Abion 203400 | 34 | 50.0% | 6.6% |
| Pharos iBio 388870 | 33 | 45.5% | 9.1% |
| Qurient 115180 | 32 | 62.5% | 24.7% |
| Inveni 015360 | 31 | 12.9% | 0.8% |
| curacle 365270 | 31 | 45.2% | 20.0% |
| ADforus 397810 | 30 | 46.7% | 39.7% |
| Sungchang Enterprise Holdings 000180 | 29 | 24.1% | 61.5% |
| AprilBio 397030 | 27 | 55.6% | 79.4% |
| Eusu Holdings 000700 | 23 | 34.8% | -78.4% |
| Kanaph Therapeutics 0082N0 | 23 | 78.3% | 4.7% |
| D&D Pharmatech 347850 | 22 | 59.1% | 52.3% |
| ImmuneOncia Therapeutics 424870 | 22 | 68.2% | 10.0% |
| Mezzion Pharma 140410 | 18 | 22.2% | 34.8% |
| Inventera 0007J0 | 16 | 56.3% | 25.4% |
| Parataxis Korea 288330 | 16 | 56.3% | 16.5% |
| Kainos Medicine 284620 | 15 | 60.0% | -40.7% |
| IDIS Holdings 054800 | 14 | 0.0% | – |
| Asia Holdings 002030 | 10 | 20.0% | 46.3% |
| Solborn 035610 | 5 | 20.0% | 20.0% |
Source: Financial Supervisory Service, OpenDART, employee status in each company's 2025 annual business report. Every KOSPI and KOSDAQ company discloses its employees, average tenure and average pay by gender each year. Compiled by The Hardest Market.